This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Skyrizi
  • /
  • BI 655066 / ABBV-066 (Risankizumab) in Moderate to...
Clinical trial

BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Read time: 3 mins
Last updated:29th Feb 2016
Identifier: NCT02672852
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest